Global Synthetic Biology Market to Reach $75.9 Billion by 2030 at a CAGR of 26.3%
20 sept. 2022 05h33 HE
|
Research and Markets
Dublin, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market Size, Share, Trends, By Technology, By Tools, By Application, By End-use, and By Region Forecast to 2030" report has been...
Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation
19 sept. 2022 07h00 HE
|
Codex DNA, Inc.
SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the...
Synlogic Achieves Research Milestone in Collaboration with Roche for Development of Novel Synthetic Biotic to Treat Inflammatory Bowel Disease
06 sept. 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced today...
Synlogic Granted FDA Fast Track Designation for SYNB1353 for the Treatment of Homocystinuria (HCU)
23 août 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...
DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
22 août 2022 10h40 HE
|
DoubleRainbow Biosciences
Lexington, MA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- DoubleRainbow Biosciences (“Double Rainbow”), a sustainable biotech company harnessing bioengineering to improve the quality of human health,...
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
15 août 2022 23h41 HE
|
Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
Senior communications leader joins Manus Bio
11 août 2022 12h08 HE
|
Manus Bio
BOSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Manus Bio, the leading biomanufacturer of natural products, has appointed Frederik Bjoerndal as its Vice President of Corporate Communications. Frederik...
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
11 août 2022 06h58 HE
|
Synlogic, Inc.
– Three clinical data readouts across three programs expected in H2 2022 – – PKU Phase 3 readiness activities underway for planned start in H1 2023 – – $106.8 million in cash, cash equivalents and...
Synthetic Biology Market Global Outlook and Forecast 2022-2027: Synthetic Biology Brings a Paradigm Shift in the Field of Biomedicine and With it Lucrative Growth Opportunities
09 août 2022 07h13 HE
|
Research and Markets
Dublin, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market - Global Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global synthetic...
Synlogic Announces Second Quarter 2022 Conference Call and Webcast
28 juil. 2022 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...